6 to 8 weeks
For decisions of wider scope: entering a market, an investment, or securing coverage.
| Variant | Question | What it combines | Timing | From (USD) |
|---|---|---|---|---|
| Opportunity assessment | Whether to enter a country with a product or portfolio, and through which route | Patient and value sizing, competition, access route, reference price, 3-year scenarios, recommendation | 6 weeks, one country | 20,000 |
| Business case | Justification of the investment and the conditions for making it | Opportunity assessment + revenue model and, depending on scope, margin after acquisition cost, launch investment and payment terms + 6-interview KHIN Panel | 8 weeks, one country | 30,000 |
| Access and pricing strategy | How to secure coverage and at what price, without affecting regional reference prices | Map of decision makers and processes, regional price corridor, 8-interview KHIN Panel, access plan with sequence and arguments | 8 weeks, one country | 32,000 |
Implementation (negotiations with payers or presentations to committees on the client's behalf), quantitative surveys, and formal clinical or pharmacoeconomic studies. Implementation support can be agreed separately as working sessions with a defined scope.
An initial 30-minute call is used to set out the question and the scope; the proposal, with the price and the delivery date, follows in writing.